Tri Locum Partners »

Kenvue shares owned by Tri Locum Partners

Quarter-by-quarter ownership of Kenvue (KVUE) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in Kenvue

Tip: Access up to 7 years of quarterly data

All positions including Kenvue held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kenvue by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 699k 21.53
2023-09-30 $1.1M 55k 20.08

More positions owned by Tri Locum Partners

Abbvie (ABBV)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Kenvue Put Option (KVUE)
Regeneron Pharmaceuticals (REGN)
Ge Healthcare Technologies I Common Stock (GEHC)
Ascendis Pharma A/s Sponsored Adr (ASND)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Biogen Idec (BIIB)
Catalent (CTLT)
Axsome Therapeutics (AXSM)
Xenon Pharmaceuticals (XENE)
Argenx Se Sponsored Adr (ARGX)
Natera (NTRA)
Legend Biotech Corp Sponsored Ads (LEGN)
Madrigal Pharmaceuticals (MDGL)

View all positions for Tri Locum Partners

Top funds holding Kenvue

Vanguard Group
T. Rowe Price Associates
Wellington Management Company
Massachusetts Financial Services
Jpmorgan Chase & Co
Bank of America Corporation
Bank of New York Mellon
Franklin Resources
Robeco Investment Management
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Marshall Wace
Laurion Capital Management
Norges Bank Investment Management

View all funds holding Kenvue